Cms-10434 #26 Cqm2018-add-ch

Centers for Medicare & Medicaid
Services
CMS eXpedited Life Cycle (XLC)

Medicaid and CHIP Program (MACPro)
CQM 2018 - Follow-Up Care for Children
Prescribed Attention-Deficit/Hyperactivity
Disorder (ADHD) Medication (ADD-CH) Core
Measure PRA Document
Version 1.0
06/25/2018

Document Number: 385-CQM 2018-ADD-CH-PRA-D
Contract Number: HHSM-500-2007-00024I: HHSM-500-T0014

CMS XLC

Table of Contents

Table of Contents
1. Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity
Disorder (ADHD) Medication (ADD-CH) Screenshots ........................................... 1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
1.9
1.10
1.11
1.12
1.13
1.14

Measurement Specifications – Path 1 ............................................................. 1
Measurement Specifications – Path 2 ............................................................. 1
Data Source .................................................................................................... 1
Date Range ..................................................................................................... 2
Definition of Population Included in the Measure – Screenshot 1 ................... 2
Definition of Population Included in the Measure – Screenshot 2 ................... 3
Performance Measure - Path 1 ....................................................................... 3
Performance Measure - Path 2 ....................................................................... 4
Deviations from Measure Specifications – Screenshot 1 ................................ 4
Deviations from Measure Specifications – Screenshot 2 ................................ 5
Combined Rate(s) from Multiple Reporting Units ............................................ 5
Additional Notes/Comments on Measure (Optional) ....................................... 5
Optional Measure Stratification – Screenshot 1 .............................................. 6
Optional Measure Stratification – Screenshot 2 .............................................. 6

Appendix A: Acronyms ................................................................................................. 7

List of Figures
Figure 1: Measurement Specifications – Path 1 .............................................................. 1
Figure 2: Measurement Specifications – Path 2 .............................................................. 1
Figure 3 : Data Source .................................................................................................... 1
Figure 4: Date Range ...................................................................................................... 2
Figure 5: Definition of Population Included in the Measure – Screenshot 1 .................... 2
Figure 6: Definition of Population Included in the Measure – Screenshot 2 .................... 3
Figure 7: Performance Measure - Path 1 ........................................................................ 3
Figure 8: Performance Measure - Path 2 ........................................................................ 4
Figure 9: Deviations from Measure Specifications – Screenshot 1 ................................. 4
Figure 10: Deviations from Measure Specifications – Screenshot 2 ............................... 5
Figure 11: Combined Rate(s) from Multiple Reporting Units ........................................... 5
Figure 12: Additional Notes/Comments on Measure (Optional) ...................................... 5

CQM 2018 - Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication (ADD-CH) Core Measure PRA
Document Version 1.0
i
06/25/2018

CMS XLC

List of Tables

Figure 13 : Optional Measure Stratification – Screenshot 1 ............................................ 6
Figure 14: Optional Measure Stratification – Screenshot 2 ............................................. 6

List of Tables
No table of figures entries found.

CQM 2018 - Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication (ADD-CH) Core Measure PRA
Document Version 1.0
ii
06/25/2018

CMS XLC

Measurement Specifications – Path 1

1. Follow-Up Care for Children Prescribed AttentionDeficit/Hyperactivity Disorder (ADHD) Medication
(ADD-CH) Screenshots
1.1

Measurement Specifications – Path 1

Figure 1: Measurement Specifications – Path 1

1.2

Measurement Specifications – Path 2

Figure 2: Measurement Specifications – Path 2

1.3

Data Source

Figure 3 : Data Source

CQM 2018 - Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication (ADD-CH) Core Measure PRA
Document Version 1.0
1
06/25/2018

CMS XLC

1.4

Date Range

Date Range

Figure 4: Date Range

1.5

Definition of Population Included in the Measure – Screenshot 1

Figure 5: Definition of Population Included in the Measure – Screenshot 1

CQM 2018 - Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication (ADD-CH) Core Measure PRA
Document Version 1.0
2
06/25/2018

CMS XLC

1.6

Definition of Population Included in the Measure – Screenshot 2

Definition of Population Included in the Measure – Screenshot 2

Figure 6: Definition of Population Included in the Measure – Screenshot 2

1.7

Performance Measure - Path 1

Figure 7: Performance Measure - Path 1

CQM 2018 - Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication (ADD-CH) Core Measure PRA
Document Version 1.0
3
06/25/2018

CMS XLC

1.8

Performance Measure - Path 2

Performance Measure - Path 2

Figure 8: Performance Measure - Path 2

1.9

Deviations from Measure Specifications – Screenshot 1

Figure 9: Deviations from Measure Specifications – Screenshot 1

CQM 2018 - Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication (ADD-CH) Core Measure PRA
Document Version 1.0
4
06/25/2018

CMS XLC

Deviations from Measure Specifications – Screenshot 2

1.10 Deviations from Measure Specifications – Screenshot 2

Figure 10: Deviations from Measure Specifications – Screenshot 2

1.11 Combined Rate(s) from Multiple Reporting Units

Figure 11: Combined Rate(s) from Multiple Reporting Units

1.12 Additional Notes/Comments on Measure (Optional)

Figure 12: Additional Notes/Comments on Measure (Optional)

CQM 2018 - Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication (ADD-CH) Core Measure PRA
Document Version 1.0
5
06/25/2018

CMS XLC

Optional Measure Stratification – Screenshot 1

1.13 Optional Measure Stratification – Screenshot 1
Note: Same N/D/R sets are displayed under each of the stratification categories

Figure 13 : Optional Measure Stratification – Screenshot 1

1.14 Optional Measure Stratification – Screenshot 2
Note: Same N/D/R sets are displayed under each of the stratification categories

Figure 14: Optional Measure Stratification – Screenshot 2

CQM 2018 - Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication (ADD-CH) Core Measure PRA
Document Version 1.0
6
06/25/2018

CMS XLC

Optional Measure Stratification – Screenshot 2

Appendix A: Acronyms
Table 1: Acronyms
Acronym

Definition

CQM

Child Quality Measures

PRA

Paperwork Reduction Act of 1995

CQM 2018 - Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication (ADD-CH) Core Measure PRA
Document Version 1.0
7
06/25/2018